Open Nav

Rifat Pamukcu

Presidet & CEO

RxMP Therapeutics, Inc.

Dr. Pamukcu MD FAIMBE was previously a Founder, Board Director CSO/CMO of Cell Pathways, Inc. He directed the basic science, preclinical, clinical, and regulatory programs Dr. Pamukcu was instrumental in raising over $140 million of investment capital and participated in the transformation of CPI from a private to a publicly traded company on NASDAQ. OSI Pharmaceuticals acquired CPI in June 2003. Dr. Pamukcu is a Board Director of Atrin Pharmaceuticals, Virion Therapeutics and Midway Pharmaceuticals. He is an advisor to the Wallace H. Coulter Foundation and a member of the Oversight Committees for the Coulter Funds at Emory/Georgia Tech and Drexel Universities. He received his B.A. from the Johns Hopkins University and his M.D. from the University Wisconsin School of Medicine. He has authored over 110 journal articles, book chapters and abstracts in the fields of gastroenterology, cancer, and cancer chemoprevention. Dr. Pamukcu is an inventor on over 150 patents.

This speaker's sessions: